These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 1692506

  • 1. N-myc oncogene expression and amplification in metastatic lesions of stage IV-S neuroblastoma.
    Garvin J, Bendit I, Nisen PD.
    Cancer; 1990 Jun 01; 65(11):2572-5. PubMed ID: 1692506
    [Abstract] [Full Text] [Related]

  • 2. N-myc oncogene RNA expression in neuroblastoma.
    Nisen PD, Waber PG, Rich MA, Pierce S, Garvin JR, Gilbert F, Lanzkowsky P.
    J Natl Cancer Inst; 1988 Dec 21; 80(20):1633-7. PubMed ID: 2461451
    [Abstract] [Full Text] [Related]

  • 3. N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases.
    Nakagawara A, Sasazuki T, Akiyama H, Kawakami K, Kuwano A, Yokoyama T, Kume K.
    Cancer; 1990 May 01; 65(9):1960-7. PubMed ID: 2196987
    [Abstract] [Full Text] [Related]

  • 4. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM.
    N Engl J Med; 1993 Mar 25; 328(12):847-54. PubMed ID: 8441429
    [Abstract] [Full Text] [Related]

  • 5. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
    Shimada H, Stram DO, Chatten J, Joshi VV, Hachitanda Y, Brodeur GM, Lukens JN, Matthay KK, Seeger RC.
    J Natl Cancer Inst; 1995 Oct 04; 87(19):1470-6. PubMed ID: 7674334
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
    Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM.
    Cancer Res; 1992 Mar 01; 52(5):1364-8. PubMed ID: 1737399
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
    Matsunaga T, Shirasawa H, Tanabe M, Ohnuma N, Kawamura K, Etoh T, Takahashi H, Simizu B.
    Int J Cancer; 1994 Sep 15; 58(6):793-8. PubMed ID: 7523310
    [Abstract] [Full Text] [Related]

  • 17. Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview.
    Tsuchida Y, Hemmi H, Inoue A, Obana K, Yang HW, Hayashi Y, Kanda N, Shimatake H.
    Tumour Biol; 1996 Sep 15; 17(2):65-74. PubMed ID: 8658015
    [Abstract] [Full Text] [Related]

  • 18. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
    Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nuñez G.
    Am J Pathol; 1993 Dec 15; 143(6):1543-50. PubMed ID: 8256847
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.